Xu L, Shen T, Li Y, Wu X
Clin Rev Allergy Immunol. 2025; 68(1):29.
PMID: 40085180
DOI: 10.1007/s12016-025-09041-6.
Song G, Yu Q, Xing X, Fan X, Xu S, Zhang W
Cell Death Dis. 2025; 16(1):127.
PMID: 39994235
PMC: 11850776.
DOI: 10.1038/s41419-025-07417-2.
Sheng Q, Yu Q, Lu S, Yang M, Fan X, Su H
Cell Mol Life Sci. 2025; 82(1):86.
PMID: 39985591
PMC: 11846817.
DOI: 10.1007/s00018-025-05596-x.
Shan C, Dong K, Wen D, Ye Z, Hu F, Zekraoui M
BMC Plant Biol. 2025; 25(1):147.
PMID: 39905321
PMC: 11792417.
DOI: 10.1186/s12870-025-06127-3.
Sun Y, Sun Y, He X, Li S, Xu X, Feng Y
BMC Genomics. 2024; 25(1):1071.
PMID: 39528936
PMC: 11556200.
DOI: 10.1186/s12864-024-10972-1.
N6-Methyladenosine methylation modification in breast cancer: current insights.
Zhang G, Cheng C, Wang X, Wang S
J Transl Med. 2024; 22(1):971.
PMID: 39468547
PMC: 11514918.
DOI: 10.1186/s12967-024-05771-x.
Reading the mA-encoded epitranscriptomic information in development and diseases.
Chen Y, Zhou Z, Chen Y, Chen D
Cell Biosci. 2024; 14(1):124.
PMID: 39342406
PMC: 11439334.
DOI: 10.1186/s13578-024-01293-7.
Mapping the Influence of Light Intensity on the Transgenerational Genetic Architecture of .
Mei J, Che J, Shi Y, Fang Y, Wu R, Zhu X
Curr Issues Mol Biol. 2024; 46(8):8148-8169.
PMID: 39194699
PMC: 11352948.
DOI: 10.3390/cimb46080482.
N6-methyladenosine RNA methyltransferase CpMTA1 mediates CpAphA mRNA stability through a YTHDF1-dependent m6A modification in the chestnut blight fungus.
Zhao L, Wei X, Chen F, Yuan L, Chen B, Li R
PLoS Pathog. 2024; 20(8):e1012476.
PMID: 39159278
PMC: 11361730.
DOI: 10.1371/journal.ppat.1012476.
RNA N6-methyladenosine methylation in influenza A virus infection.
Liu X, Chen W, Li K, Sheng J
Front Microbiol. 2024; 15:1401997.
PMID: 38957616
PMC: 11217485.
DOI: 10.3389/fmicb.2024.1401997.
Exploring the role of m A writer RBM15 in cancer: a systematic review.
Cao Y, Qiu G, Dong Y, Zhao W, Wang Y
Front Oncol. 2024; 14:1375942.
PMID: 38915367
PMC: 11194397.
DOI: 10.3389/fonc.2024.1375942.
An α-ketoglutarate conformational switch controls iron accessibility, activation, and substrate selection of the human FTO protein.
Burns D, Khatiwada B, Singh A, Purslow J, Potoyan D, Venditti V
Proc Natl Acad Sci U S A. 2024; 121(25):e2404457121.
PMID: 38865275
PMC: 11194561.
DOI: 10.1073/pnas.2404457121.
The catalytic mechanism of the RNA methyltransferase METTL3.
Corbeski I, Vargas-Rosales P, Bedi R, Deng J, Coelho D, Braud E
Elife. 2024; 12.
PMID: 38470714
PMC: 10932547.
DOI: 10.7554/eLife.92537.
Reduced DNMT1 levels induce cell apoptosis via upregulation of METTL3 in cardiac hypertrophy.
Zhang X, Nie Y, Zhang R, Yu J, Ge J
Heliyon. 2024; 10(3):e24572.
PMID: 38314261
PMC: 10837504.
DOI: 10.1016/j.heliyon.2024.e24572.
Ubiquitination and deubiquitination in the regulation of N-methyladenosine functional molecules.
Zhao Y, Huang J, Zhao K, Li M, Wang S
J Mol Med (Berl). 2024; 102(3):337-351.
PMID: 38289385
DOI: 10.1007/s00109-024-02417-9.
N6-methyladenosine methylation in kidney injury.
Wang Q, Fan X, Sheng Q, Yang M, Zhou P, Lu S
Clin Epigenetics. 2023; 15(1):170.
PMID: 37865763
PMC: 10590532.
DOI: 10.1186/s13148-023-01586-7.
N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.
Peng W, Liu F, Jiang J, Yuan H, Zhang Z, Yang L
Genes Dis. 2023; 10(2):554-567.
PMID: 37223505
PMC: 10201599.
DOI: 10.1016/j.gendis.2022.02.014.
Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases.
Xu Y, Zhang Y, Luo Y, Qiu G, Lu J, He M
Cell Death Discov. 2023; 9(1):170.
PMID: 37202385
PMC: 10195832.
DOI: 10.1038/s41420-023-01435-9.
m6A methylation: Critical roles in aging and neurological diseases.
Fan Y, Lv X, Chen Z, Peng Y, Zhang M
Front Mol Neurosci. 2023; 16:1102147.
PMID: 36896007
PMC: 9990872.
DOI: 10.3389/fnmol.2023.1102147.
METTL3 Regulates Osteoclast Biological Behaviors via iNOS/NO-Mediated Mitochondrial Dysfunction in Inflammatory Conditions.
Li D, He J, Fang C, Zhang Y, He M, Zhang Z
Int J Mol Sci. 2023; 24(2).
PMID: 36674918
PMC: 9862541.
DOI: 10.3390/ijms24021403.